相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Two Decades of Active Surveillance for Prostate Cancer in a Single-Center Cohort: Favorable Outcomes after Transurethral Resection of the Prostate
Sarah Hagmann et al.
CANCERS (2022)
Hormone Treatment of Prostate Cancer: Evidence for Usage and Safety
Muhieddine Labban et al.
UROLOGIC CLINICS OF NORTH AMERICA (2022)
The cost, survival, and quality-of-life implications of guideline-discordant imaging for prostate cancer
Aaron N. Winn et al.
CANCER REPORTS (2022)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Early health economic analysis of 1.5 T MRI-guided radiotherapy for localized prostate cancer: Decision analytic modelling
Charisma Hehakaya et al.
RADIOTHERAPY AND ONCOLOGY (2021)
Lifetime Health and Economic Outcomes of Active Surveillance, Radical Prostatectomy, and Radiotherapy for Favorable-Risk Localized Prostate Cancer
Koen Degeling et al.
VALUE IN HEALTH (2021)
Disparities in prostate cancer incidence and mortality rates: Solvable or not?
Simone Badal et al.
PROSTATE (2020)
A Cost-Effectiveness and Quality of Life Analysis of Different Approaches to the Management and Treatment of Localized Prostate Cancer
Aleksandra Harat et al.
FRONTIERS IN ONCOLOGY (2020)
Economic evaluation of robot-assisted radical prostatectomy compared to open radical prostatectomy for prostate cancer treatment in Ontario, Canada
Anna Parackal et al.
CUAJ-Canadian Urological Association Journal (2020)
Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
C. Parker et al.
ANNALS OF ONCOLOGY (2020)
The ProtecT randomised trial cost-effectiveness analysis comparing active monitoring, surgery, or radiotherapy for prostate cancer
Sian M. Noble et al.
BRITISH JOURNAL OF CANCER (2020)
Toxicity reduction required for MRI-guided radiotherapy to be cost-effective in the treatment of localized prostate cancer
Leif-Erik D. Schumacher et al.
BRITISH JOURNAL OF RADIOLOGY (2020)
Modelling the lifetime cost-effectiveness of radical prostatectomy, radiotherapy and active monitoring for men with clinically localised prostate cancer from median 10-year outcomes in the ProtecT randomised trial
S. Sanghera et al.
BMC CANCER (2020)
Angiogenesis Inhibition in Prostate Cancer: An Update
Chandrani Sarkar et al.
CANCERS (2020)
The cost of prostate cancer care to society and to patients in the United States.
Nicholas George Zaorsky et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Literature review of the burden of prostate cancer in Germany, France, the United Kingdom and Canada
J. Smith-Palmer et al.
BMC UROLOGY (2019)
Prostate Cancer, Version 2.2019
James L. Mohler et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2019)
Germline and Somatic Mutations in Prostate Cancer for the Clinician
Heather H. Cheng et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2019)
The burden of prostate cancer is associated with human development index: evidence from 87 countries, 1990-2016
Rajesh Sharma
EPMA JOURNAL (2019)
Targeting Angiogenesis in Prostate Cancer
Zsombor Melegh et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Total Medicare Costs Associated With Diagnosis and Treatment of Prostate Cancer in Elderly Men
Justin G. Trogdon et al.
JAMA ONCOLOGY (2019)
Cost-effectiveness Analysis of Active Surveillance Strategies for Men with Low-risk Prostate Cancer
Niranjan J. Sathianathen et al.
EUROPEAN UROLOGY (2019)
Cost-Effectiveness of Primary Radiation Therapy Versus Radical Prostatectomy for Intermediate-to High-Risk Prostate Cancer
Jennifer A. Dorth et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
The Role of Multiparametric Magnetic Resonance Imaging in Active Surveillance for Men with Low-risk Prostate Cancer: A Cost-effectiveness Modeling Study
Sejal Patel et al.
EUROPEAN UROLOGY ONCOLOGY (2018)
The cost-effectiveness of active surveillance compared to watchful waiting and radical prostatectomy for low risk localised prostate cancer
Chunhuan Lao et al.
BMC CANCER (2017)
Robot-assisted surgery in gynecological oncology: current status and controversies on patient benefits, cost and surgeon conditions - a systematic review
Steffen E. Kristensen et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2017)
Robot-assisted surgery in elderly and very elderly population: our experience in oncologic and general surgery with literature review
Graziano Ceccarelli et al.
AGING CLINICAL AND EXPERIMENTAL RESEARCH (2017)
Economic burden of cancer across the European Union: a population-based cost analysis
Ramon Luengo-Fernandez et al.
LANCET ONCOLOGY (2013)
Systematic review and economic modelling of the relative clinical benefit and cost-effectiveness of laparoscopic surgery and robotic surgery for removal of the prostate in men with localised prostate cancer
C. Ramsay et al.
HEALTH TECHNOLOGY ASSESSMENT (2012)